Stanford Cow Studies confirm development of Clathrin GQD was completed through a global coordinated effort.

RSS Feed

Stanford Cow Studies confirm development of Clathrin GQD was completed through a global coordinated effort.

October 7th, 2023

Awake Goy

In 2010, Vitaliano backed Clathrin studies at Stanford.

Protein in Cow Brains Holds Promise for Alternative Energy. ¹

Cow Brain Protein May Hold Alternative Energy Promise. ²

The Heilshorn Group : Members who ran studies. ³

So there must have been news articles on what they were doing in 2010, Stanford was key. They were figuring out how to grow the triskelion. Use Cow Clathrin to do so. ⁴

Sarah Heilshorn oversaw the studies for Vitaliano. ⁵

Sarah Heilshorn is all about using hydrogels. Hydrogels are used by Heilshorn in drug delivery and tissue engineering. ⁶

Heilshorn’s paper on Clathrin. ⁷

And another. ⁸

She coauthored with members of the Chinese Academy of Science. ⁹

She did the Clathrin work, connected by funding through NIH. Her team was from everywhere, a lot of Thousand Talents Chinese.

Sarah was director of Geballe Laboratory for advanced materials.

She developed the hydrogen Clathrin technology and found ways to build damaged heart, spinal cord, … , nervous system.

Sarah’s early work is cited in Vitaliano early work. Stanford news release from 2010 celebrating findings. ¹⁰

2010 saw the completion of their Clathrin GQD neural interface technology. These cow trials were key.

“Our aspiration is to enable bio-based quantum computing at the nanoscale [level] by using the same completely reversible processes that keep heat to a minimum in living things,” said Vitaliano.

Clathrin, a protein found in every cell of the human body, could become a self-assembler of future information processing systems that are smaller, faster and cheaper than today’s computer circuitry.

Boston-based ExQor Technologies said it has demonstrated that Clathrin can be formed into nano-sized biolasers suitable for transmitting information. It expects the technology will initially be used in medical applications.

One very exciting prospect is using ExQor’s nano-lasers for repairing and growing neurons in the human nervous system.

Another powerful application for ExQor’s nanolasers is disposable, safe, ultrasensitive, ultrafast biochips for DNA and RNA detection.

While researching clathrin for medical applications, ExQor discovered that the material exhibits quantum properties useful for biocomputing applications, including nanoscale lasing.

Clathrin-nanoparticles were PEGylated and delivered intranasally. Animals were sacrificed 3 hours after intranasal administration of Clathrin.

Another powerful application for ExQor’s nanolasers is disposable, safe, ultrasensitive, ultrafast biochips for DNA and RNA detection.

From the article; “Protein Computing, Bio-based Quantum Computing and Nano-sized biolasers from ExQor Technologies”, May 28, 2010 ¹¹

Living proteins inside our bodies enable smarter computing circuits than the fastest supercomputers–our brains–a one of those proteins is now being harnesses for future quantum computing devices. Look for protein-based electronics first for medical, then for quantum computing within five years.

Clathrin, a protein found in every cell of the human body, could become a self-assembler of future information processing systems that are smaller, faster and cheaper than today’s computer circuitry, according to a company investigating the technology. Boston-based ExQor Technologies said it has demonstrated that the material can be formed into nano-sized biolasers suitable for transmitting information. It expects the technology will initially be used in medical applications. The precision of clathrin’s self-assembly process, and ultra-small size also could be used to improve solar cells and batteries with nanoscale electronic and photonic properties not possible with silicon.

from the article “Will proteins revolutionize computing?”, 2010 ¹²

2010 delivery system complete, 2013 consolidation of brain initiatives world wide. The mRNA was prepared 2013. ¹³ 2014 first beta test was turkey. 2015 Moderna tests in China, with MERS inserts. ¹⁴